FDA releases draft guidance on master protocol studies

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FDA has published a draft guidance titled “Master Protocols–Efficient Clinical Trial Design Strategies to Expedite Development of Cancer Drugs and Biologics.”

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe

YOU MAY BE INTERESTED IN

Login